SEC Form 4 · accession 0001179110-15-001013
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claudia de Oliveira Ribeiro Hirawat
Officer — President
Period of report
Jan 15, 2015
Accepted (ET)
Jan 16, 2015 · 7:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2015 | M | 2,396 | $10.85 | A | 41,396 | D | |
| Common StockF2 | Jan 15, 2015 | S | 2,149 | $57.19 | D | 39,247 | D | |
| Common Stock | holding | — | — | — | 194 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F4 | $10.85 | Jan 15, 2015 | M | 2,396 | D | — | May 15, 2023 | Common Stock | 2,396 | 67,084 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.66 to $57.61 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Pursuant to the Separation and General Release Agreement dated December 16, 2014 between the Reporting Person and the Issuer (the Separation Agreement), the remaining options vest on January 16, 2015
- F4Pursuant to the Separation Agreement, the remaining options will expire on January 31, 2016.